TuSimple, Y-mAbs Therapeutics And Some Other Big Stocks Moving Lower In Today's Pre-Market Session

Loading...
Loading...

U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.

  • Y-mAbs Therapeutics, Inc. YMAB fell 37.4% to $5.62 in pre-market trading after FDA's Oncologic Drugs Advisory Committee (ODAC) raised concerns regarding the efficacy of the company’s potential pediatric neuroblastoma treatment, omburtamab. JP Morgan downgraded Y-mAbs Therapeutics from Neutral to Underweight and lowered the price target from $16 to $7.
  • TuSimple Holdings Inc. TSP fell 16.3% to $5.28 in pre-market trading after the company reported termination of CEO and the initiation of a search for a new CEO. The company also faced federal investigations over alleged improper financing and transferring technology to a Chinese startup, Hydron Inc.
  • Uxin Limited UXIN fell 11.1% to $3.62 in pre-market trading after declining around 10% on Friday.
  • Petróleo Brasileiro S.A. - Petrobras PBR fell 8.8% to $12.27 in pre-market trading.
  • Nuvalent, Inc. NUVL shares declined 6.5% to $33.06 in pre-market trading. Nuvalent shares jumped 60% on Friday after the company reported preliminary Phase 1 clinical data from the ARROS-1 trial that support the best-in-class potential of NVL-520 for patients with ROS1-positive NSCLC.
  • Hanesbrands Inc. HBI declined 5.3% to $6.82 in pre-market trading.
  • XPeng Inc. XPEV dropped 5.2% to $6.53 in pre-market trading. Citigroup, on Friday, downgraded XPeng from Buy to Sell and announced a $3.18 price target.
  • Stem, Inc. STEM dropped 4% to $12.85 in pre-market trading. UBS recently initiated coverage on the stock with a Buy rating and a $19 price target.

Also check this out: US Stock Futures Down Following Friday's Rally; Crude Oil Edges Lower .

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasPremarket LosersTop Losers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...